HighTower Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$709K Sell
4,674
-1,291
-22% -$196K ﹤0.01% 2243
2025
Q1
$898K Sell
5,965
-748
-11% -$113K ﹤0.01% 2025
2024
Q4
$1.24M Sell
6,713
-3,698
-36% -$683K ﹤0.01% 1815
2024
Q3
$2.05M Sell
10,411
-619
-6% -$122K ﹤0.01% 1510
2024
Q2
$2.27M Sell
11,030
-1,017
-8% -$209K ﹤0.01% 1376
2024
Q1
$3.28M Buy
12,047
+820
+7% +$223K 0.01% 1162
2023
Q4
$2.65M Sell
11,227
-2,752
-20% -$649K ﹤0.01% 1282
2023
Q3
$2.76M Sell
13,979
-340
-2% -$67.2K 0.01% 1207
2023
Q2
$3.01M Sell
14,319
-4,173
-23% -$877K 0.01% 1131
2023
Q1
$3.72M Sell
18,492
-15,151
-45% -$3.05M 0.01% 984
2022
Q4
$7.35M Buy
33,643
+5,709
+20% +$1.25M 0.02% 701
2022
Q3
$5.53M Buy
27,934
+6,949
+33% +$1.38M 0.01% 760
2022
Q2
$4.48M Sell
20,985
-9,375
-31% -$2M 0.01% 871
2022
Q1
$8.64M Sell
30,360
-498
-2% -$142K 0.02% 677
2021
Q4
$11.7M Buy
30,858
+11,773
+62% +$4.45M 0.03% 547
2021
Q3
$7.86M Buy
19,085
+112
+0.6% +$46.1K 0.02% 647
2021
Q2
$7.02M Buy
18,973
+700
+4% +$259K 0.02% 664
2021
Q1
$5.29M Buy
18,273
+1,638
+10% +$474K 0.02% 716
2020
Q4
$4.13M Buy
16,635
+86
+0.5% +$21.3K 0.02% 646
2020
Q3
$3.75M Buy
16,549
+446
+3% +$101K 0.02% 650
2020
Q2
$2.81M Buy
16,103
+1,307
+9% +$228K 0.02% 692
2020
Q1
$1.88M Buy
14,796
+114
+0.8% +$14.5K 0.01% 766
2019
Q4
$2.25M Buy
14,682
+357
+2% +$54.6K 0.01% 813
2019
Q3
$1.9M Buy
14,325
+331
+2% +$43.9K 0.01% 902
2019
Q2
$1.99M Buy
13,994
+423
+3% +$60.1K 0.01% 904
2019
Q1
$1.97M Buy
13,571
+665
+5% +$96.6K 0.01% 858
2018
Q4
$1.46M Buy
12,906
+6,725
+109% +$759K 0.01% 892
2018
Q3
$831K Buy
6,181
+881
+17% +$118K 0.01% 1214
2018
Q2
$590K Sell
5,300
-4,072
-43% -$453K ﹤0.01% 1371
2018
Q1
$987K Buy
9,372
+5,020
+115% +$529K 0.01% 1081
2017
Q4
$478K Sell
4,352
-1,088
-20% -$120K ﹤0.01% 1463
2017
Q3
$586K Buy
+5,440
New +$586K 0.01% 1355
2016
Q3
Sell
-8,632
Closed -$714K 1870
2016
Q2
$714K Buy
+8,632
New +$714K 0.01% 1010